AF
VINC

Amalgamated Financial’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Amalgamated Financial’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$11K Buy
+134
New +$16.6K ﹤0.01% 2886

Other funds holding VINC

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SRC
Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amalgamated Financial's VINC Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Vincerx Pharma, Inc. Common Stock (VINC) in Q1 2022: 134 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #2886 among its holdings.

67 funds tracked by Wall St. Rank hold VINC as of Q1 2022.

  • Amalgamated Financial held 134 shares of Vincerx Pharma, Inc. Common Stock worth $11K as of Q1 2022.
  • Vincerx Pharma, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
  • Vincerx Pharma, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2886 holding.
  • 67 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.